Thioamides are a class of chemical compounds defined by a simple but consequential swap: a sulfur atom replaces the oxygen atom that normally sits in an amide bond. In medicine, the term most often refers to antithyroid drugs like methimazole and propylthiouracil (PTU), which remain the primary medications for managing an overactive thyroid gland. But the thioamide family extends further than endocrinology, encompassing antibiotics used against drug-resistant tuberculosis and even emerging tools in peptide chemistry research. Understanding what these compounds do, when they are used, and what can go wrong with them matters for anyone prescribed one or curious about how they work.
What Makes a Thioamide a Thioamide
At a molecular level, an ordinary amide has a carbon bonded to an oxygen and a nitrogen. In a thioamide, the oxygen is swapped for sulfur. That single-atom change alters the molecule’s behavior in ways that matter for drug design: the sulfur atom changes how the molecule forms hydrogen bonds with biological targets, increases its ability to dissolve in fatty tissues, and shifts its preferred three-dimensional shape. These properties can make thioamide-containing drugs interact with their targets differently than their oxygen-containing cousins, affecting how long the drug lasts in the body and how tightly it grips the enzyme or protein it is supposed to block.1Europe PMC. Unlocking the potential of the thioamide group in drug design and development
In everyday medical use, you will encounter thioamides mainly in two settings. The first and most common is the treatment of hyperthyroidism, especially Graves’ disease, where methimazole and PTU are the go-to drugs. The second is tuberculosis treatment, where ethionamide and its relative prothionamide serve as second-line antibiotics when front-line drugs fail. A handful of other thioamide compounds appear in chemistry labs and early-stage drug research, but these two clinical applications are where patients actually encounter them.
How Antithyroid Thioamides Work
When your thyroid gland is overproducing hormones, the problem traces back to an enzyme called thyroid peroxidase. This enzyme is responsible for key steps in building thyroid hormones, including attaching iodine to the protein thyroglobulin. Methimazole and PTU interfere with this process by inhibiting thyroid peroxidase or by diverting oxidized iodine away from thyroglobulin, effectively choking off the supply line for new thyroid hormone production.2PubMed Central. Bioinorganic chemistry in thyroid gland: effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions Neither drug destroys existing thyroid hormone already circulating in the blood, which is why it takes days to weeks before patients feel a difference.
PTU has a second trick that methimazole lacks. Outside the thyroid gland, your body normally converts the storage form of thyroid hormone (T4) into its more active form (T3). PTU blocks this conversion. In studies of patients without functioning thyroid glands who were maintained on a fixed dose of T4, adding PTU caused serum T3 levels to drop significantly, from about 120 to 83 nanograms per deciliter, with levels bouncing back after the drug was stopped.3PubMed Central. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man This extra mechanism makes PTU useful in thyroid storm, a life-threatening surge of thyroid hormones where you need to reduce active hormone levels as fast as possible.
How the Body Handles These Drugs
Methimazole and PTU behave quite differently once swallowed. Methimazole barely binds to blood proteins and has a half-life of roughly three to five hours, while PTU is about 80% protein-bound and clears faster, with a half-life of only one to two hours.4PubMed. Clinical pharmacokinetics of antithyroid drugs In practice, this means methimazole can often be dosed once daily, while PTU typically requires dosing two or three times a day. Both drugs concentrate inside the thyroid gland itself, where they keep working on iodine metabolism for longer than their blood levels would suggest.
The convenience of once-daily dosing is one reason methimazole is generally preferred over PTU for most patients. Fewer pills per day translates to better adherence over months of treatment. PTU still has specific niches where it is the better choice, particularly in the first trimester of pregnancy and during thyroid storm, as discussed below.
Treating Graves’ Disease and Achieving Remission
Graves’ disease is the most common reason someone ends up on a thioamide. The usual approach is to start the drug, bring thyroid hormone levels back to normal over several weeks, then gradually lower the dose while monitoring blood work. A standard course runs at least 12 to 18 months, though the question of how long to keep treating is one of the more debated topics in endocrinology.
The long-term remission rate after a course of antithyroid drugs sits around 50%, though that figure varies enormously depending on how long the drug is taken and where in the world the study was done. In the United States, where shorter treatment courses of 12 to 18 months have been typical, remission rates have historically been only about 20% to 30%. In European studies with longer treatment durations of five to six years, the rate climbs to 50% to 60%.5Endocrinology and Metabolism. Thyroid Antithyroid Drug Treatment in Graves’ Disease A Korean study found that relapse rates dropped steadily with longer treatment, falling from about 42% after one year of therapy to 19% after more than six years. This kind of data has pushed many endocrinologists toward keeping patients on low-dose methimazole for extended periods rather than stopping after the traditional year and a half.6PubMed Central. Long-term management of Graves disease: a narrative review
An older study tracking 96 patients treated with primary drug therapy found that only about 16% achieved a prolonged remission lasting more than two years.7JAMA Internal Medicine. Antithyroid Drugs and Radioactive Iodine: Fifteen Years’ Experience With Graves’ Disease On the other hand, a long-term follow-up of 45 patients who had been in clinical remission for over ten years after thionamide treatment showed that the vast majority remained euthyroid, though a small fraction developed subclinical hypothyroidism or had mild elevations in thyroid hormones.8PubMed Central. Thyroid function and histology in forty-five patients with hyperthyroid Graves’ disease in clinical remission more than ten years after thionamide drug treatment The takeaway is that remission is possible, but relapse is common, and ongoing monitoring is essential even after the drug is stopped.
Common and Mild Side Effects
Most people who take methimazole or PTU tolerate them reasonably well, but minor side effects are not rare. Skin reactions are among the most frequent complaints: itching, rashes, and hives send many patients back to their doctor within the first few weeks. Joint pain and gastrointestinal discomfort also crop up. These reactions are usually manageable. Switching from one thioamide to the other sometimes resolves the problem, though cross-reactivity between the two drugs does occur in a minority of patients.
Rarer skin reactions have also been documented. At least one case report describes erythema nodosum, painful red nodules typically appearing on the shins, developing about 15 days after starting methimazole.9ScienceDirect / Saudi Pharmaceutical Journal (PubMed Central). A case of severe erythema nodosum induced by methimazole While individual case reports do not establish frequency, they serve as reminders that skin symptoms during thioamide treatment deserve medical attention rather than being dismissed as routine.
Agranulocytosis
The side effect that keeps endocrinologists watchful is agranulocytosis, a drastic drop in white blood cells called neutrophils. Without enough neutrophils, the body cannot fight off infections, and what starts as a sore throat and fever can escalate into a life-threatening emergency. In a retrospective analysis of 36 patients who developed this complication, fever appeared in about 83% and sore throat in 75% as the earliest warning signs.10PubMed. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism
The risk is not spread evenly across treatment. A review of cases at one institution found that the median interval between starting the drug and the first symptoms of agranulocytosis was 33 days, with a range of 23 to 55 days. This suggests the danger window is concentrated in the first ten weeks or so of treatment. The same data pointed to a dose relationship for methimazole: patients who developed agranulocytosis were taking roughly twice the daily dose compared to those who did not.11PubMed. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature Once the drug was stopped and any infection treated, white blood cell counts recovered within a median of 15 days, though two fatal cases were noted among referred patients in that series.
The underlying mechanism is complex. Some evidence points to direct toxicity: the drug accumulates inside neutrophils, where enzymes like myeloperoxidase can convert it into reactive molecules that damage the cells. Immune-mediated destruction also plays a role, particularly with PTU, which can trigger antineutrophil cytoplasmic antibodies (ANCA) that target neutrophils for destruction.12PubMed Central. Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management This is why patients starting a thioamide are typically told to report any fever, sore throat, or mouth ulcers immediately and to get a blood count done before assuming it is just a cold.
Liver Toxicity
Both methimazole and PTU can harm the liver, but the patterns differ. Methimazole tends to cause cholestatic liver injury, where bile flow is impaired, leading to jaundice and itching. PTU is more associated with hepatocellular damage, meaning actual destruction of liver cells, which can occasionally progress to acute liver failure requiring a transplant. The distinction matters clinically: PTU-related liver failure, while rare, has been severe enough that it prompted the FDA years ago to add a black-box warning to the drug. One case report described a patient with Graves’ disease who developed acute hepatitis first on methimazole and then again on PTU after switching, illustrating that both drugs carry hepatic risk and that cross-reactivity in liver toxicity is possible.13Europe PMC. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies
Routine liver function monitoring is not universally recommended for all patients on thioamides, but baseline liver tests before starting therapy are standard practice. The practical guidance for patients is the same as with agranulocytosis: report symptoms early. Nausea, dark urine, clay-colored stools, or yellowing of the skin or eyes during treatment should prompt a call to the prescriber rather than a wait-and-see approach.
Vasculitis and Autoimmune Reactions
PTU carries a distinctive risk that methimazole does not share to the same degree: the development of ANCA-associated vasculitis. In this condition, the immune system produces antibodies that attack the walls of small blood vessels, leading to inflammation in the skin, kidneys, lungs, or other organs. The antibodies involved are usually directed against myeloperoxidase, a protein inside neutrophils.14PubMed Central. Propylthiouracil-Induced Skin Vasculitis
Vasculitis from PTU can develop even after years of treatment. One documented case involved a 41-year-old woman with Graves’ disease who had been on PTU for nearly two years before developing symptoms. Her workup showed elevated ANCA levels, and biopsy confirmed thrombotic vasculitis, leading to a diagnosis of PTU-induced vasculitis.15PubMed Central. Propylthiouracil-induced vasculitis The long lag between starting the drug and developing this complication makes it easy to miss the connection. Symptoms like unexplained joint pain, skin purpura, blood in the urine, or a persistent cough in someone on PTU should raise suspicion. Treatment involves stopping the drug, and some patients need immunosuppressive therapy.
Thioamides in Pregnancy
Managing hyperthyroidism during pregnancy creates a balancing act, since both uncontrolled thyroid disease and the drugs used to treat it pose risks to the developing fetus. The current consensus, supported by multiple systematic reviews, is that PTU is the safer option during the first trimester of pregnancy. Methimazole has been linked to a specific pattern of rare but recognizable birth defects when used in early pregnancy, including a scalp condition called aplasia cutis and a group of anomalies sometimes referred to as methimazole embryopathy.16PubMed. The safety of methimazole and propylthiouracil in pregnancy: a systematic review
A more recent meta-analysis confirmed that PTU is the safer alternative for treating hyperthyroidism during the first trimester.17PubMed Central. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis However, because of PTU’s own risk of serious liver toxicity, many guidelines recommend switching back to methimazole after the first trimester, once the window of greatest teratogenic risk has passed. The practical result is a drug switch partway through pregnancy, which requires careful monitoring and dose adjustment.
Thioamides in Tuberculosis Treatment
Ethionamide and its close relative prothionamide are thioamide antibiotics used as second-line agents against tuberculosis, typically reserved for cases where the bacterium has developed resistance to first-line drugs like isoniazid and rifampicin. Their mechanism is distinct from antithyroid thioamides but elegant in its own right. Inside the bacterium, ethionamide gets activated and forms a chemical bond with a molecule called NAD. The resulting compound is a potent inhibitor of an enzyme called InhA, which the bacterium needs to build mycolic acids, essential components of its protective cell wall. Crystal structures of these drug-NAD complexes show nanomolar-level binding to InhA from both the tuberculosis and leprosy bacteria.18PubMed Central. Mechanism of thioamide drug action against tuberculosis and leprosy
The downstream effect is disruption of mycolic acid production. When ethionamide is present, bacteria lose the ability to synthesize oxygenated forms of mycolic acid, though production of other mycolic acid types may persist or even increase. The drug appears to act early in the biochemical pathway leading to oxygenated mycolic acids.19PubMed Central. Mycolic acid synthesis: a target for ethionamide in mycobacteria? Without an intact cell wall, the bacterium becomes vulnerable.
Resistance to ethionamide is a growing concern, particularly in multidrug-resistant and extensively drug-resistant tuberculosis. Mutations in the gene called ethA, which encodes the enzyme that activates ethionamide inside the bacterium, are a primary cause. Mutations in inhA itself can also drive resistance, and these often confer cross-resistance to isoniazid, since both drugs ultimately target the same enzyme. In one analysis of resistant clinical isolates, about 76% of those with high-level ethionamide resistance had mutations in either ethA or the inhA structural gene.20PubMed Central. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates This cross-resistance complicates treatment, since a patient whose tuberculosis already resists isoniazid may also get less benefit from ethionamide depending on which mutation is driving the resistance.
Thioamides in Veterinary Medicine
Hyperthyroidism is not just a human problem. It is one of the most common hormonal disorders in older cats, and methimazole is the standard medical treatment. The drug works the same way in cats as in people, suppressing thyroid hormone production by inhibiting thyroid peroxidase.21PubMed. Optimal testing for thyroid hormone concentration after treatment with methimazole in healthy and hyperthyroid cats Cats may receive methimazole as pills, a flavored liquid, or a transdermal gel applied to the inner ear flap. Side effects in cats parallel those in humans, including gastrointestinal upset, skin reactions, and less commonly, drops in white blood cell or platelet counts. Veterinarians typically monitor blood work regularly in treated cats, especially during the first few months.
The feline use of methimazole is worth knowing about for a practical reason: if you have a cat on this medication, you should handle the pills or gel with care. The drug is absorbed through skin, and prolonged ungloved contact could theoretically affect your own thyroid function over time.
Thioamides Beyond the Clinic
Outside their role as drugs, thioamides have found a niche in chemical biology and peptide research. Scientists can swap the normal oxygen-containing amide bonds in a peptide chain for thioamide bonds at specific positions, which lets them study how individual backbone bonds contribute to a protein’s folding, stability, and function. A method published in the Journal of Organic Chemistry demonstrated efficient incorporation of thioamide bonds into peptides during solid-phase synthesis, working for 19 of the 20 standard amino acids (histidine being the exception) and allowing one or multiple substitutions in the same peptide chain without significant chemical side reactions.22ACS Publications. Site-Specific Incorporation of Multiple Thioamide Substitutions into a Peptide Backbone via Solid Phase Peptide Synthesis
This kind of work is still largely confined to research labs, but it speaks to the broader potential of the thioamide modification. Because the sulfur-for-oxygen swap subtly changes a molecule’s electronic properties, shape, and interactions with biological targets, thioamide-modified peptides could eventually lead to drugs with improved stability in the body or novel mechanisms of action. For now, the technique serves mainly as a precision tool for understanding how proteins work at the atomic level, one bond at a time.